Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06231043
Other study ID # 100/66
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date April 27, 2022
Est. completion date April 15, 2023

Study information

Verified date January 2024
Source Lampang Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients presented with acute pain from renal colic, the standard of care are prescribed NSAIDs, most common drug used is intramuscular (IM) Diclofenac injected at the gluteal muscle. Due to adverse effects in some patients, the nursing council has banned the injection by nurses. Since then, there has been a change in treatment by using intravascular (IV) Tramadol. According to various research, Diclofenac has a higher efficacy in controlling pain compared to other medications. In clinical practice, Tramadol has less efficacy of decreasing pain and a longer onset of action. At presence, there has been no research performed comparing the efficacy between these two drugs especially from the viewpoint of time dimension.


Description:

To compare the efficacy Diclofenac 75 mg IM versus Tramadol 50 mg IV in patients with acute pain from renal colic.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date April 15, 2023
Est. primary completion date March 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Days and older
Eligibility Inclusion Criteria: 1. Age over 18 years 2. Acute pain in renal/ureteric colic 3. Pain score more than 4 4. Confirmation diagnosis by ultrasound bedside Exclusion Criteria: 1. Refused to participate in the research 2. Pregnancy 3. Contraindicated of Diclofenac or Tramadol 4. Urinary tract infection 5. Skin infection at Buttock area 6. Acute kidney injury 7. CKD stage III, IV, V 8. Bilateral severe hydronephrosis 9. Physician refusal

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Diclofenac/Tramadol
Arm Drug1 :Diclofenac 75 mg (3 ml) IM injection by doctor, then followed by normal saline 20 ml IV injection (equal to Tramadol diluted) by nurse. Arm Drug2 :Normal saline 3 ml IM injection by doctor (equal to Diclofenac 75 mg), then followed by Tramadol 50 mg (1 ml) dilute with normal saline 19 ml (total 20 ml )IV injection by nurse.

Locations

Country Name City State
Thailand Lampang hospital Lampang

Sponsors (1)

Lead Sponsor Collaborator
Lampang Hospital

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diclofenac 75 mg IM or Tramadol 50 mg IV Time to pain relief 30,60,90,120 minutes
See also
  Status Clinical Trial Phase
Withdrawn NCT01685658 - Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations Phase 4
Completed NCT02878148 - Conditional Imaging Prescription Strategy for Exploration of Acute Uncomplicated Renal Colic N/A
Completed NCT03704623 - Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic Phase 4
Completed NCT01339624 - Nasal Fentanyl And Renal Colic N/A
Completed NCT04441762 - Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management. Phase 2/Phase 3